THE WHAT? Walgreens Boots Alliance is mulling the sale of its namesake Boots business, according to a report published by Sky News.

THE DETAILS The drug store owner is said to have appointed Goldman Sachs to advise on the options available, which could include a spin off or disposal. The UK high street pharmacy chain is said to be valued at between £10 billion and £5 billion.

THE WHY? In a statement issued to Sky News, the company said, “Walgreens Boots Alliance does not comment on market speculation and Boots is an important part of the Group.

“However, it is accurate that WBA announced a renewed set of priorities and strategic direction for the Group in October, which includes a more pointed focus on North America and healthcare.

“As underlined during the last WBA investor conference, the Group continues to be very pleased with the performance of Boots and the International division as a whole.”